Refine
Has Fulltext
- yes (14)
Is part of the Bibliography
- yes (14)
Document Type
- Journal article (14)
Language
- English (14)
Keywords
- Parkinson's disease (2)
- autoantibodies (2)
- inflammatory neuropathy (2)
- neurofascin (2)
- neurology (2)
- neuropathy (2)
- passive transfer (2)
- skin punch biopsy (2)
- Antiparanodal Autoantibodies (1)
- CIDP (1)
- Charcot–Marie–Tooth disease type 1A (1)
- Diabetes mellitus (1)
- Guillain-Barre-Syndrome (1)
- IENFD (1)
- IgG4 (1)
- Langerhans cells (1)
- MIBG scintigraphy (1)
- Merkel cell density (1)
- Nodo-parandopathy (1)
- adsorption (1)
- anti-contactin-1 (1)
- antibodies (1)
- autoantibody (1)
- autoimmune nodopathy (1)
- barrier (1)
- behavioral disorders (1)
- binding (1)
- binding analysis (1)
- biopsies (1)
- cell binding assay (1)
- chronic constriction nerve injury (1)
- complement deposition (1)
- complex regional pain syndrome (1)
- contactin (1)
- dermal B cells (1)
- diagnostic markers (1)
- enzyme assays (1)
- enzyme-linked immunoassays (1)
- extracellular domain (1)
- glycine receptor (1)
- glycine receptor autoantibodies (1)
- glycosylation (1)
- inflammatory demyelinating polyradiculoneuropathy (1)
- intraepidermal nerve fibre density (1)
- macrophages (1)
- mast cells (1)
- motor proteins (1)
- multiple system atrophy (1)
- musk myasthenia gravis (1)
- nerve biopsy (1)
- nerve fibers (1)
- nerve tumor (1)
- neuroleukemiosis (1)
- nociceptive Schwann cells (1)
- node of ranvier (1)
- ontactin 1 (1)
- pain (1)
- paranodopathy (1)
- periperal nerve (1)
- peripheral nervous system (1)
- reproducible outcome measure (1)
- skin biopsy (1)
- switch (1)
- tissue resident T cells (1)
Diabetes Mellitus Is a Possible Risk Factor for Nodo-paranodopathy With Antiparanodal Autoantibodies
(2022)
Background and Objectives
Nodo-paranodopathies are peripheral neuropathies with dysfunction of the node of Ranvier. Affected patients who are seropositive for antibodies against adhesion molecules like contactin-1 and neurofascin show distinct clinical features and a disruption of the paranodal complex. An axoglial dysjunction is also a characteristic finding of diabetic neuropathy. Here, we aim to investigate a possible association of antibody-mediated nodo-paranodopathy and diabetes mellitus (DM).
Methods
We retrospectively analyzed clinical data of 227 patients with chronic inflammatory demyelinating polyradiculoneuropathy and Guillain-Barré syndrome from multiple centers in Germany who had undergone diagnostic testing for antiparanodal antibodies targeting neurofascin-155, pan-neurofascin, contactin-1–associated protein 1, and contactin-1. To study possible direct pathogenic effects of antiparanodal antibodies, we performed immunofluorescence binding assays on human pancreatic tissue sections.
Results The frequency of DM was 33.3% in seropositive patients and thus higher compared with seronegative patients (14.1%, OR = 3.04, 95% CI = 1.31–6.80). The relative risk of DM in seropositive patients was 3.4-fold higher compared with the general German population. Seropositive patients with DM most frequently harbored anti–contactin-1 antibodies and had higher antibody titers than seropositive patients without DM. The diagnosis of DM preceded the onset of neuropathy in seropositive patients. No immunoreactivity of antiparanodal antibodies against pancreatic tissue was detected.
Discussion
We report an association of nodo-paranodopathy and DM. Our results suggest that DM may be a potential risk factor for predisposing to developing nodo-paranodopathy and argue against DM being induced by the autoantibodies. Our findings set the basis for further research investigating underlying immunopathogenetic connections.